Easier, Noninvasive Diagnosis of Neurological Disorders
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LAB INDUSTRY REPORT
NATIONAL LAB REPORTER
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
The rule would ensure Medicare coverage of newly approved breakthrough devices, but have stricter evidence standards.
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
Recent study suggests a new test may help doctors detect Lyme disease during the early stages when treatment is likely to be more effective.
While still in its infancy, recent research shows the combination of AI and wearables can accurately detect early SARS-CoV-2 infection.
Recent developments suggest that we are on the precipice of a new age offering expanded options for Alzheimer’s diagnosis.
Researchers find that three out of four blood tests produced different results depending on if they were used for White or Black people.
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Research team creates a promising new mass spectrometry-based blood lipid test.